A slight short-term negative impact is witnessed on United Kingdom veterinary healthcare, primarily due to the reduced veterinary visits, along with the shortage of veterinary medicines, during the outbreak of COVID-19. The country was in lockdown and had suspended trade with other countries and implemented travel restrictions. This affected the import and export activities of veterinary medicines and diagnostics, leading to a decline in sales of many products. Supply disruption and medicine shortages of veterinary medicines have been observed in the country, primarily due to the temporary lockdowns of manufacturing sites, export bans, and increased demand for medicine, for the treatment of COVID-19.

The government is taking measures to mitigate the supply of medicines. For instance, the European Medicines Agency issued guidance for companies responsible for veterinary medicines, with respect to the adaptations to the regulatory framework, primarily to address the challenges faced during this pandemic situation.

The rising technological advancements and increasing awareness of zoonotic and foodborne diseases are key factors propelling the growth of the studied market. Bovine tuberculosis (bTB) is caused by Mycobacterium Bovis, and it is one of the most serious health problems for the cattle industry in the United Kingdom, with the England government alone spending GBP 70 million a year on disease control, with the cost to industry estimated to be a further GBP 50 million, as per the Zoonosis Report UK, 2019.

Additionally, the growing product launch in the United Kingdom may also help the market to grow. For instance, in October 2018, MSD Animal Health announced the launch of BRAVECTO Plus in the United Kingdom, which is a topical solution for cats for treating external and internal parasite infestations. Hence, owing to these factors, the market for veterinary healthcare in the United Kingdom is expected to witness rapid growth, over the forecast period.

Free Sample report for this report is available :- https://www.statzyreports.com/report/sr497769/united-kingdom-veterinary-healthcare-market

Key Market Trends

The Molecular Diagnostics Segment Dominates the United Veterinary Healthcare Veterinary Healthcare Market

In the current pandemic, the government authorities, such as the British Veterinary Association, recommended veterinary hospitals and clinics prioritize urgent and emergency visits and procedures. This may reduce the adoption and usage of diagnostic equipment used in veterinary healthcare management.

Molecular diagnostics refers to the class of tests performed on an animal that can assess its health at the molecular level. It identifies specific sequences in genes, DNA, RNA, and proteins and provides insights on whether the animal has a disease or may suffer from a disease in the future. Molecular diagnostic tests are faster and have more sensitivity when compared to conventional tests. However, they are more expensive than other diagnostic tests.

The majority of the commercial products in the United Kingdom veterinary molecular diagnostics market are available in the form of kits. These kits are predominantly based on PCR techniques and help screen a family of related disorders. Meanwhile, the kits based on microarrays are steadily increasing their market share.

Polymerase chain reaction (PCR) has become one of the standard procedures in diagnosing almost all viral diseases in veterinary medicine, owing to its high sensitivity, versatility, and reproducibility. In the past few decades, it has become an indispensable component of routine veterinary diagnostics. In veterinary sciences, the identification and control of pathogens in poultry, domestic, and wild animals represent continuous challenges.

Moreover, many diagnostic techniques have been developed to identify individual infectious agents to identify and confirm the pathogens or genetic elements. The latest molecular diagnostic technologies are more advantageous, as they offer high throughput results, are more sensitive, and require less time.

Moreover, market players are focusing on frequent product launches, which is driving the growth of the market studied. For instance, in December 2019, Agri-Food and Biosciences Institute launched a new bovine respiratory virus PCR test for various respiratory disease viruses in cattle, such as Bovine Respiratory Syncytial Virus (BRSV), Infectious Bovine Rhinotracheitis (IBR), and Parainfluenza virus type 3 (PI3), in Europe including United Kingdom.

Also, in March 2019, MiDOG LLC launched its new All-in-One Microbial Test based Next-Generation DNA Sequencing (NGS). The test identifies all aerobic and anaerobic bacteria, fungi, as well as antibiotic resistance in dogs. Thus, such product launches is likely to have positive impact on the verticle growth.

Competitive Landscape

The United Kingdom veterinary healthcare market has been rapidly evolving since the past few years, where technology concerning biotech, genomics, artificial intelligence, cloud computing, and big data witnessed significant growth, which resulted in competition among large animal health companies and collaborations with technologically advanced startups. Moreover, the industry observed significant mergers and acquisitions in recent years. Thus, UK veterinary healthcare is highly competitive.

Reasons to Purchase this report:

- The market estimate (ME) sheet in Excel format
- 3 months of analyst support

For sample report please visit : https://www.statzyreports.com/report/sr497769/united-kingdom-veterinary-healthcare-market
Contact Us:
Poojan Dogra
Public Relations Manager
Email : [email protected]
Email : [email protected]
(IN) - +918484035727
(US) - +1415-871-0483
Website : www.statzyreports.com